Granocyte 34 1 10*6 IU/ml inf. sol. (pwdr. + solv.) s.c./i.v. pre-filled syr. vial
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Lenograstim 263
Available from:
Chugai Pharma France
ATC code:
L03AA10
INN (International Name):
Lenograstim (RHUG-CSF)
Dosage:
1 MIU/ml
Pharmaceutical form:
Powder and solvent for solution for infusion
Composition:
Lenograstim (RHUG-CSF) 263 µg
Administration route:
Intravenous use; Subcutaneous use
Therapeutic area:
Lenograstim
Product summary:
CTI code: 165724-02 - Pack size: 5 x 263 µg + 5 x 1 ml + 2 x Injection needle - Commercialisation status: YES - FMD code: 05430000897006 - CNK code: 1308873 - Delivery mode: Medical prescription; CTI code: 165724-01 - Pack size: 263 µg + 1 ml + 2 x Injection needle - Commercialisation status: NO - Delivery mode: Medical prescription
Authorization status:
Commercialised: Yes
Authorization date:
1994-05-30
